Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,891 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy.
Johnston S, Wilson K, Varker H, Malangone-Monaco E, Juneau P, Riehle E, Satram-Hoang S, Sommer N, Ogale S. Johnston S, et al. Among authors: wilson k. Clin Colorectal Cancer. 2017 Dec;16(4):386-396.e1. doi: 10.1016/j.clcc.2017.03.014. Epub 2017 Mar 24. Clin Colorectal Cancer. 2017. PMID: 28619608 Free article.
Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants.
Gilligan AM, Franchino-Elder J, Song X, Wang C, Henriques C, Sainski-Nguyen A, Wilson K, Smith DM, Sander S. Gilligan AM, et al. Among authors: wilson k. Curr Med Res Opin. 2018 Feb;34(2):285-295. doi: 10.1080/03007995.2017.1409425. Epub 2017 Nov 30. Curr Med Res Opin. 2018. PMID: 29166800
Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin.
Gilligan AM, Franchino-Elder J, Song X, Wang C, Henriques C, Sainski-Nguyen A, Wilson K, Smith DM, Sander S. Gilligan AM, et al. Among authors: wilson k. Expert Rev Pharmacoecon Outcomes Res. 2019 Apr;19(2):203-212. doi: 10.1080/14737167.2019.1527220. Epub 2018 Oct 4. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30251553
5,891 results